With Carvykti now approved for pretreated myeloma, there are conversations that patients should have with their providers ...

Patients with heavily pretreated myeloma tended to have “really amazing results” with the CAR-T cell therapy, Carvykti.

At first, I wanted to avoid receiving chemotherapy at all costs, but I realized taking it would be the beginning of staying ...

Treatment with Enhertu “is an unprecedented approval” for patients with HER2-positive solid tumors who did not have many ...

Tecentriq plus Cabometyx conferred no overall survival benefit when compared with chemotherapy, a study showed.

The FDA has granted accelerated approval to Ojemda for patients 6 months and older with relapsed or refractory pediatric ...

Lutathera was approved for patients 12 or older with SSTR-positive gastroenteropancreatic neuroendocrine tumors, the FDA ...

The investigational drug ziftomenib is currently being evaluated for patients with relapsed/refractory NPM1-mutant acute ...

While strolling through the woods, my eyes landed on a woodpecker, whose actions sparked a cancer analogy in my mind.

A treatment combination of Anktiva and Bacillus Calmette-Guérin was approved by the FDA for certain patients with ...

Patient/provider trust, education and lifestyle choices are crucial as Black men face higher incidence and mortality in ...

A cognitive behavioral therapy for insomnia may help cancer survivors, along with ways to manage insomnia via sleep pressure, ...